All times are listed in CEST (Central European Summer Time)

Browsing Over 60 Sessions

Sort By
View
Multidisciplinary Interactive session

Place of radiotherapy in advanced SCLC treated with IO: Brain and thorax

Date
Thu, 30.03.2023
Time
08:00 - 09:00
Chairs
  • Fiona McDonald (London, United Kingdom)
Location
Auditorium 2
Controversy session

Is neoadjuvant chemo-immunotherapy superior to adjuvant immunotherapy?

Date
Thu, 30.03.2023
Time
08:00 - 09:00
Chairs
  • Lizza Hendriks (Maastricht, Netherlands)
Location
Auditorium 1
ESMO Colloquium

ESMO Colloquium supported by Eli Lilly & Company - Precision oncology beyond EGFR/ALK for NSCLC in 2023: Test, target, manage

Date
Thu, 30.03.2023
Time
09:15 - 10:45
Chairs
  • Solange Peters (Lausanne, Switzerland)
  • Benjamin Besse (Villejuif, CEDEX, France)
Location
Auditorium 4
Educational session

Resistance after IO and targeted therapies: Patterns of emergence and management

Date
Thu, 30.03.2023
Time
09:15 - 10:45
Chairs
  • Zofia Piotrowska (Boston, United States of America)
  • Suresh Senan (Amsterdam, Netherlands)
Location
Auditorium 1
Controversy session

Stereotactic RT vs surgery in early stage NCSLC

Date
Thu, 30.03.2023
Time
09:15 - 10:15
Location
Auditorium 2
Coffee break

Coffee break

Date
Thu, 30.03.2023
Time
10:45 - 11:15
Location
Exhibition and Poster area
Educational session

Peri-operative strategies in early stage NSCLC with IO and targeted therapies

Date
Thu, 30.03.2023
Time
11:15 - 12:45
Chairs
  • Jordi Remon Masip (Villejuif, Cedex, France)
  • Leah Backhus (Stanford, United States of America)
Location
Auditorium 1
Multidisciplinary Tumour Board

Stage III thymoma

Date
Thu, 30.03.2023
Time
11:15 - 12:45
Chairs
  • Nicolas Girard (Paris, France)
  • Sanjay Popat (London, United Kingdom)
Location
Auditorium 4
Educational session

Genomic alterations beyond EGFR and ALK

Date
Thu, 30.03.2023
Time
11:15 - 12:45
Chairs
  • Antonio Passaro (Milan, Italy)
  • Lyudmila Bazhenova (La Jolla, CA, United States of America)
Location
Auditorium 2
Auditorium 2 Thu, 30.03.2023 13:30 - 15:00

Janssen Pharmaceuticals - Exploring clinical perspectives in advanced EGFR-mutant NSCLC: How far we have come (ID 47)

Time
13:30 - 15:00
Chairs
  • Alfredo Addeo (Geneva, Switzerland)
  • Enriqueta Felip (Barcelona, Spain)
Location
Auditorium 2
Date
Thu, 30.03.2023
Auditorium 4 Thu, 30.03.2023 13:30 - 15:00

Amgen - Advancing the treatment landscape for lung cancer with new targets (ID 48)

Time
13:30 - 15:00
Chairs
  • Sanjay Popat (London, United Kingdom)
Location
Auditorium 4
Date
Thu, 30.03.2023
Proffered Paper session

Proffered Paper 2

Date
Thu, 30.03.2023
Time
15:10 - 16:40
Chairs
  • Martin Reck (Grosshansdorf, Germany)
Location
Auditorium 1